Viewing Study NCT06505018


Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2026-03-05 @ 9:29 PM
Study NCT ID: NCT06505018
Status: RECRUITING
Last Update Posted: 2025-09-02
First Post: 2024-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Sponsor: UNICANCER
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Triple-Negative Breast Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Telemonitoring View
None Triple Negative Breast Cancer View
None Cureety View
None Adverse events View